Existing Annotations Review

GO Term	Evidence	Action	Reason
GO:0030154 cell differentiation	IBA GO_REF:0000033	MODIFY	Summary: DLX1 is a central regulator of GABAergic interneuron differentiation in the forebrain and plays roles in hematopoietic cell differentiation. This IBA annotation is correct but too general for the core function. Reason: The IBA annotation is phylogenetically sound and the general statement is correct, but this term lacks the specificity needed to capture DLX1's primary role. DLX1's core developmental function is GABAergic interneuron specification and differentiation in the ventral telencephalon, where it acts downstream of ASCL1. More specific terms like GO:0097154 (GABAergic neuron differentiation) or GO:0021892 (cerebral cortex GABAergic interneuron differentiation) better represent the core function. Proposed replacements: GABAergic neuron differentiation cerebral cortex GABAergic interneuron differentiation Supporting Evidence: file:human/DLX1/DLX1-deep-research-falcon.md model: Edison Scientific Literature
GO:0005634 nucleus	IBA GO_REF:0000033	ACCEPT	Summary: DLX1 is a nuclear transcription factor. This is a core cellular component annotation fully supported by experimental evidence. Reason: As a homeobox transcription factor, DLX1 functions in the nucleus where it binds DNA and regulates gene transcription. This is supported by IDA evidence from PMID:14671321, IBA phylogenetic inference, and functional requirement for nuclear localization. The homeodomain is necessary for nuclear localization. This is a core localization annotation. Supporting Evidence: PMID:14671321 We report here that, in addition to the previously reported regions/cells, DLX1 is expressed in hematopoietic cells in a lineage-dependent manner and that DLX1 interacts with Smad4 through its homeodomain
GO:0006357 regulation of transcription by RNA polymerase II	IBA GO_REF:0000033	ACCEPT	Summary: DLX1 functions as a transcriptional activator or repressor through RNA polymerase II. This is a correct core function annotation. Reason: DLX1 is a sequence-specific DNA-binding transcription factor that regulates RNA pol II transcription at target genes. UniProt states it acts as transcriptional activator or repressor. This IBA annotation correctly captures this core molecular process. Supporting Evidence: PMID:14671321 the resulting complex translocates to the nucleus to regulate transcription
GO:0048706 embryonic skeletal system development	IBA GO_REF:0000033	KEEP AS NON CORE	Summary: DLX1 plays roles in craniofacial development including jaw morphogenesis and odontogenesis. This annotation represents a secondary (non-core) developmental role. Reason: DLX genes including DLX1 are expressed in pharyngeal arches and contribute to craniofacial skeletal patterning. However, this is a pleiotropic effect rather than the primary function. The core function of DLX1 is GABAergic interneuron specification in the forebrain. Craniofacial roles are developmentally important but represent secondary functions of this transcription factor.
GO:0000981 DNA-binding transcription factor activity, RNA polymerase II-specific	IBA GO_REF:0000033	ACCEPT	Summary: DLX1 is a sequence-specific DNA-binding transcription factor that regulates RNA polymerase II transcription. This is a core molecular function annotation. Reason: This annotation accurately captures DLX1's primary molecular function as a homeodomain-containing transcription factor that binds specific DNA sequences to regulate transcription. Supported by multiple evidence codes (IBA, ISA, IEA) and structural domain information.
GO:0000978 RNA polymerase II cis-regulatory region sequence-specific DNA binding	IBA GO_REF:0000033	ACCEPT	Summary: DLX1 binds to specific DNA sequences (TAAT/ATTA motifs) at cis-regulatory regions including enhancers and promoters. This is a core molecular function. Reason: DLX1 contains a homeodomain that recognizes TAATTA-type DNA motifs at enhancers and promoters. Recent work shows DLX1 binds enhancers with specific motif grammar to modulate chromatin loops. This IBA annotation accurately represents the sequence-specific DNA binding activity.
GO:0000981 DNA-binding transcription factor activity, RNA polymerase II-specific	IEA GO_REF:0000120	ACCEPT	Summary: Duplicate of IBA annotation above. This IEA annotation is redundant but correct. Reason: This is a duplicate annotation with different evidence (IEA vs IBA for the same term). Both are correct. IEA annotations from automated pipelines are acceptable when they correctly identify core functions, as in this case.
GO:0003677 DNA binding	IEA GO_REF:0000120	ACCEPT	Summary: DLX1 contains a homeodomain and binds DNA. However, this term is too general compared to more specific sequence-specific binding terms. Reason: While this term is very general, it is not incorrect. DLX1 does bind DNA through its homeodomain. The more specific terms (GO:0000978, GO:1990837) provide better functional detail, but this broad parent term can be retained as it is accurate. IEA annotations at this level are acceptable for coverage.
GO:0005634 nucleus	IEA GO_REF:0000120	ACCEPT	Summary: Duplicate nucleus localization annotation. Redundant with IBA and IDA annotations but correct. Reason: This is a duplicate of the IBA annotation for nucleus localization. While redundant, it is correct and represents automated inference that agrees with phylogenetic and experimental data.
GO:0006355 regulation of DNA-templated transcription	IEA GO_REF:0000002	ACCEPT	Summary: DLX1 regulates transcription. This term is correct but overlaps substantially with the more specific GO:0006357 (regulation of transcription by RNA polymerase II). Reason: This is a valid but more general annotation than GO:0006357. Both terms are in the transcription regulation hierarchy. The more specific RNA pol II term is preferable, but this general term is not incorrect and can be retained.
GO:0030154 cell differentiation	IEA GO_REF:0000043	MODIFY	Summary: Duplicate of IBA annotation above, from keyword mapping. Same assessment applies. Reason: This is a duplicate IEA annotation of the IBA annotation reviewed above. Same reasoning applies - the term is correct but too general. Should be replaced with more specific GABAergic neuron differentiation terms. Proposed replacements: GABAergic neuron differentiation
GO:0000977 RNA polymerase II transcription regulatory region sequence-specific DNA binding	IEA GO_REF:0000107	ACCEPT	Summary: DLX1 binds specific sequences at transcriptional regulatory regions. This overlaps with GO:0000978 but is essentially equivalent and correct. Reason: This term is essentially synonymous with GO:0000978 (RNA polymerase II cis-regulatory region sequence-specific DNA binding) already annotated. Both accurately describe DLX1's DNA binding to regulatory elements. The slight terminology difference does not warrant modification.
GO:0003682 chromatin binding	IEA GO_REF:0000107	ACCEPT	Summary: DLX1 engages chromatin as a transcription factor and can modulate chromatin architecture. This is a valid annotation for a DNA-binding TF. Reason: Transcription factors that bind DNA inherently interact with chromatin. Recent evidence shows DLX1 can modulate promoter-enhancer chromatin loops. While not as specific as sequence-specific DNA binding terms, chromatin binding is a valid molecular function for DLX1.
GO:0006357 regulation of transcription by RNA polymerase II	IEA GO_REF:0000107	ACCEPT	Summary: Duplicate of IBA annotation above. This IEA annotation is redundant but correct. Reason: This is another duplicate annotation of the IBA-supported GO:0006357 term. The annotation is correct and represents the core biological process regulated by DLX1.
GO:0045597 positive regulation of cell differentiation	IEA GO_REF:0000107	ACCEPT	Summary: DLX1 promotes GABAergic interneuron differentiation and acts in hematopoietic cell differentiation. The positive regulation aspect is correct for the core GABAergic function. Reason: DLX1 positively regulates GABAergic interneuron differentiation as part of the ASCL1→DLX1/2 cascade that specifies GABAergic fate. While the term is somewhat general, the directionality (positive) is appropriate for the core function. This annotation can be retained.
GO:0045944 positive regulation of transcription by RNA polymerase II	IEA GO_REF:0000107	ACCEPT	Summary: DLX1 can act as transcriptional activator or repressor. This term captures only the activation function and may be incomplete. Reason: UniProt indicates DLX1 acts as both activator and repressor. This annotation captures the activation function. Experimental evidence from PMID:14671321 (IMP) supports positive regulation of transcription. The negative regulation is captured by GO:0000122 annotation. Both directions are biologically relevant.
GO:0046533 negative regulation of photoreceptor cell differentiation	IEA GO_REF:0000107	KEEP AS NON CORE	Summary: DLX1 plays roles in retinal cell differentiation in developing retina, promoting amacrine and bipolar cells. This term from mouse orthologs is a peripheral function. Reason: UniProt notes DLX1 plays a role in terminal differentiation of interneurons including amacrine and bipolar cells in developing retina (by similarity from mouse). This is a valid developmental role but peripheral to the core forebrain GABAergic interneuron function. Mark as non-core.
GO:1902871 positive regulation of amacrine cell differentiation	IEA GO_REF:0000107	KEEP AS NON CORE	Summary: DLX1 promotes amacrine cell differentiation in the developing retina. This is a peripheral developmental function based on mouse data. Reason: This annotation is based on mouse ortholog data (ISS annotation exists). Amacrine cells are retinal interneurons, and this represents a developmental role of DLX genes outside the core forebrain GABAergic specification function. Valid but non-core.
GO:0005654 nucleoplasm	IDA GO_REF:0000052	ACCEPT	Summary: Nucleoplasm is a sub-compartment of the nucleus. This IDA annotation provides more specific localization information. Reason: This Human Protein Atlas IDA annotation provides more specific nuclear sub-localization data. Nucleoplasm is a valid and more specific cellular component term for a nuclear transcription factor. This complements the broader nucleus annotations.
GO:1990837 sequence-specific double-stranded DNA binding	IDA PMID:28473536 Impact of cytosine methylation on DNA binding specificities ...	ACCEPT	Summary: DLX1 binds double-stranded DNA with sequence specificity through its homeodomain. This IDA annotation provides direct experimental evidence for DNA binding. Reason: PMID:28473536 used methylation-sensitive SELEX to systematically analyze TF binding specificities. This provides direct experimental evidence for sequence-specific dsDNA binding by DLX1. This is a core molecular function appropriately supported by experimental data. Supporting Evidence: PMID:28473536 By analysis of 542 human TFs with methylation-sensitive SELEX (systematic evolution of ligands by exponential enrichment), we found that there are also many TFs that prefer CpG-methylated sequences. Most of these are in the extended homeodomain family
GO:0000785 chromatin	ISA GO_REF:0000113	ACCEPT	Summary: This is a cellular component annotation placing DLX1 at chromatin. Transcription factors localize to chromatin when binding DNA. Reason: This ISA annotation from TFClass database correctly places DNA-binding transcription factors at chromatin. DLX1 functions at chromatin to regulate gene transcription. This is appropriate for sequence-specific TFs.
GO:0000981 DNA-binding transcription factor activity, RNA polymerase II-specific	ISA GO_REF:0000113	ACCEPT	Summary: Another instance of the core molecular function annotation from TFClass. Redundant but correct. Reason: Third instance of this annotation with ISA evidence from TFClass database. Correct annotation for a homeodomain transcription factor.
GO:0000122 negative regulation of transcription by RNA polymerase II	IMP PMID:14671321 Homeoprotein DLX-1 interacts with Smad4 and blocks a signali...	ACCEPT	Summary: DLX1 can act as transcriptional repressor. PMID:14671321 shows DLX1 blocks activin A signaling by interfering with SMAD-mediated transcription. Reason: PMID:14671321 demonstrated that DLX1 interacts with SMAD4 and blocks TGF-beta superfamily signaling, effectively acting as a transcriptional repressor in this context. The IMP evidence shows DLX1 can negatively regulate transcription. This complements the positive regulation annotation and reflects the dual activator/repressor role noted in UniProt. Supporting Evidence: PMID:14671321 We show that it blocks multiple signals from TGF-beta superfamily cytokines such as activin A, TGF-beta1, and BMP-4, including differentiation of a hematopoietic cell line by activin A
GO:0005515 protein binding	IPI PMID:14671321 Homeoprotein DLX-1 interacts with Smad4 and blocks a signali...	REMOVE	Summary: Generic protein binding annotation based on SMAD4 interaction. This term is not informative about specific function. Reason: While technically correct (DLX1 does bind SMAD4), the generic "protein binding" term provides no functional information and should be avoided per curation guidelines. If a more specific term for SMAD binding or transcription factor binding exists, that would be preferable, but the generic protein binding term should be removed. Supporting Evidence: PMID:14671321 Homeoprotein DLX-1 interacts with Smad4 and blocks a signaling pathway from activin A in hematopoietic cells.
GO:0005634 nucleus	IDA PMID:14671321 Homeoprotein DLX-1 interacts with Smad4 and blocks a signali...	ACCEPT	Summary: Another nucleus annotation with direct IDA evidence. Redundant with other nucleus annotations but experimentally supported. Reason: This IDA annotation from PMID:14671321 provides direct experimental evidence for nuclear localization. While redundant with IBA and other evidence, experimental confirmation of localization is valuable. Supporting Evidence: PMID:14671321 Homeoprotein DLX-1 interacts with Smad4 and blocks a signaling pathway from activin A in hematopoietic cells.
GO:0030514 negative regulation of BMP signaling pathway	IMP PMID:14671321 Homeoprotein DLX-1 interacts with Smad4 and blocks a signali...	KEEP AS NON CORE	Summary: DLX1 inhibits BMP4 signaling by interfering with SMAD-mediated transcription. This is experimentally demonstrated but represents a secondary regulatory role in hematopoietic cells. Reason: PMID:14671321 demonstrated that DLX1 blocks BMP4 signaling in hematopoietic cells through interaction with SMAD4. This is a valid regulatory function but is not the core developmental role of DLX1. The primary function is GABAergic interneuron specification in the forebrain. This BMP regulation represents a secondary function in hematopoietic contexts. Supporting Evidence: PMID:14671321 We show that it blocks multiple signals from TGF-beta superfamily cytokines such as activin A, TGF-beta1, and BMP-4
GO:0045944 positive regulation of transcription by RNA polymerase II	IMP PMID:14671321 Homeoprotein DLX-1 interacts with Smad4 and blocks a signali...	ACCEPT	Summary: DLX1 can act as transcriptional activator. This IMP annotation provides experimental evidence for the activation function. Reason: This IMP annotation from PMID:14671321 provides experimental evidence for DLX1's role as transcriptional activator. Together with the GO:0000122 negative regulation annotation, this captures the dual activator/repressor function. Core annotation. Supporting Evidence: PMID:14671321 DLX1 has been reported to be temporally and spatially coexpressed with BMP-4 during embryogenesis in selected contexts
GO:0071560 cellular response to transforming growth factor beta stimulus	IMP PMID:14671321 Homeoprotein DLX-1 interacts with Smad4 and blocks a signali...	KEEP AS NON CORE	Summary: DLX1 responds to and modulates TGF-beta signaling in hematopoietic cells. This is a secondary regulatory function in specific cellular contexts. Reason: PMID:14671321 shows DLX1 participates in cellular responses to TGF-beta superfamily ligands by blocking SMAD signaling. This is a valid function but specific to hematopoietic cell contexts. Not a core developmental function related to GABAergic interneuron specification. Supporting Evidence: PMID:14671321 these cytokines bind to their respective receptor, a regulatory Smad is phosphorylated and becomes associated with Smad4, the common Smad, and the resulting complex translocates to the nucleus to regulate transcription
GO:0071773 cellular response to BMP stimulus	IMP PMID:14671321 Homeoprotein DLX-1 interacts with Smad4 and blocks a signali...	KEEP AS NON CORE	Summary: DLX1 modulates cellular responses to BMP signaling in hematopoietic cells. Secondary regulatory function in specific contexts. Reason: Similar to TGF-beta response, this annotation captures DLX1's role in modulating BMP signaling in hematopoietic cells. Valid but peripheral to core forebrain GABAergic function. Supporting Evidence: PMID:14671321 DLX1 interacts with Smad4 through its homeodomain. We show that it blocks multiple signals from TGF-beta superfamily cytokines such as activin A, TGF-beta1, and BMP-4
GO:1903845 negative regulation of cellular response to transforming growth factor beta stimulus	IMP PMID:14671321 Homeoprotein DLX-1 interacts with Smad4 and blocks a signali...	KEEP AS NON CORE	Summary: DLX1 negatively regulates cellular responses to TGF-beta by blocking SMAD signaling. Secondary function in hematopoietic contexts. Reason: This annotation captures the mechanistic role of DLX1 in blocking TGF-beta signaling responses through SMAD4 interaction. Experimentally supported but represents a regulatory function in hematopoietic cells rather than the core developmental role. Supporting Evidence: PMID:14671321 Taken together, these data suggest that DLX1 may function as a regulator of multiple signals from TGF-beta superfamily members in broad biological contexts during blood production
GO:0045597 positive regulation of cell differentiation	ISS GO_REF:0000024	ACCEPT	Summary: Duplicate ISS annotation of the IEA annotation above. Same assessment - correct but general. Reason: This ISS annotation based on mouse ortholog agrees with other evidence that DLX1 positively regulates differentiation, particularly GABAergic interneuron differentiation. The annotation is correct though general.
GO:0045944 positive regulation of transcription by RNA polymerase II	ISS GO_REF:0000024	ACCEPT	Summary: Duplicate ISS annotation based on mouse ortholog. Same assessment as IMP and IEA versions - correct core function. Reason: This ISS annotation based on mouse Dlx1 ortholog correctly identifies the transcriptional activation function. Agrees with IMP experimental evidence.
GO:0046533 negative regulation of photoreceptor cell differentiation	ISS GO_REF:0000024	KEEP AS NON CORE	Summary: Duplicate ISS annotation for retinal development function. Same assessment as IEA version - valid but non-core. Reason: This ISS annotation based on mouse ortholog data represents the same retinal development function as the IEA annotation above. Valid developmental role but peripheral to core forebrain GABAergic interneuron function.
GO:1902871 positive regulation of amacrine cell differentiation	ISS GO_REF:0000024	KEEP AS NON CORE	Summary: Duplicate ISS annotation for amacrine cell differentiation. Same assessment as IEA version - valid but non-core. Reason: This ISS annotation based on mouse ortholog represents the same retinal amacrine cell function as the IEA annotation. Valid but non-core developmental role.

Core Functions

Core transcription factor function - DLX1 binds TAATTA-type DNA motifs at enhancers and promoters to regulate RNA polymerase II transcription, acting as both activator and repressor. Essential for GABAergic interneuron specification in the ventral telencephalon.

Molecular Function:

DNA-binding transcription factor activity, RNA polymerase II-specific

Directly Involved In:

GABAergic neuron differentiation cerebral cortex GABAergic interneuron differentiation

Cellular Locations:

nucleus nucleoplasm

Sequence-specific DNA binding function - DLX1 recognizes and binds specific TAAT/ATTA DNA sequences at cis-regulatory regions through its homeodomain. Can modulate chromatin architecture and promoter-enhancer loop topology in a motif-dependent manner.

Molecular Function:

RNA polymerase II cis-regulatory region sequence-specific DNA binding

Cellular Locations:

chromatin

References

GO_REF:0000002

Gene Ontology annotation through association of InterPro records with GO terms

GO_REF:0000024

Manual transfer of experimentally-verified manual GO annotation data to orthologs by curator judgment of sequence similarity

GO_REF:0000033

Annotation inferences using phylogenetic trees

GO_REF:0000043

Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping

GO_REF:0000052

Gene Ontology annotation based on curation of immunofluorescence data

GO_REF:0000107

Automatic transfer of experimentally verified manual GO annotation data to orthologs using Ensembl Compara

GO_REF:0000113

Gene Ontology annotation of human sequence-specific DNA binding transcription factors (DbTFs) based on the TFClass database

GO_REF:0000120

Combined Automated Annotation using Multiple IEA Methods

PMID:14671321

Homeoprotein DLX-1 interacts with Smad4 and blocks a signaling pathway from activin A in hematopoietic cells.

DLX1 is expressed in hematopoietic cells in a lineage-dependent manner

"We report here that, in addition to the previously reported regions/cells, DLX1 is expressed in hematopoietic cells in a lineage-dependent manner"
DLX1 interacts with Smad4 through its homeodomain

"DLX1 interacts with Smad4 through its homeodomain"
DLX1 blocks multiple signals from TGF-beta superfamily cytokines

"We show that it blocks multiple signals from TGF-beta superfamily cytokines such as activin A, TGF-beta1, and BMP-4"
DLX1 functions as a regulator of TGF-beta superfamily signals during blood production

"Taken together, these data suggest that DLX1 may function as a regulator of multiple signals from TGF-beta superfamily members in broad biological contexts during blood production"

PMID:28473536

Impact of cytosine methylation on DNA binding specificities of human transcription factors.

Systematic analysis of 542 human TFs using methylation-sensitive SELEX

"By analysis of 542 human TFs with methylation-sensitive SELEX (systematic evolution of ligands by exponential enrichment), we found that there are also many TFs that prefer CpG-methylated sequences"
Many TFs prefer CpG-methylated sequences, most in extended homeodomain family

"Most of these are in the extended homeodomain family"
Homeodomain specificity for methylcytosine depends on direct hydrophobic interactions

"Structural analysis showed that homeodomain specificity for methylcytosine depends on direct hydrophobic interactions with the methylcytosine 5-methyl group"
Many developmentally important TFs from several families prefer to bind mCpG

"This study provides a systematic examination of the effect of an epigenetic DNA modification on human TF binding specificity and reveals that many developmentally important proteins display preference for mCpG-containing sequences"

file:human/DLX1/DLX1-deep-research-falcon.md

Deep research report on DLX1

📚 Additional Documentation

Deep Research Falcon

(DLX1-deep-research-falcon.md)

provider: falcon
model: Edison Scientific Literature
cached: false
start_time: '2026-01-11T23:22:02.396833'
end_time: '2026-01-11T23:29:10.628373'
duration_seconds: 428.23
template_file: templates/gene_research_go_focused.md
template_variables:
organism: human
gene_id: DLX1
gene_symbol: DLX1
uniprot_accession: P56177
protein_description: 'RecName: Full=Homeobox protein DLX-1;'
gene_info: Name=DLX1;
organism_full: Homo sapiens (Human).
protein_family: Belongs to the distal-less homeobox family. .
protein_domains: Distal-less_Homeobox_TF. (IPR050460); HD. (IPR001356); HD_metazoa.
(IPR020479); Homeobox_CS. (IPR017970); Homeodomain-like_sf. (IPR009057)
provider_config:
timeout: 600
max_retries: 3
parameters:
allowed_domains: []
temperature: 0.1
citation_count: 29

Question

Gene Research for Functional Annotation

⚠️ CRITICAL: Gene/Protein Identification Context

BEFORE YOU BEGIN RESEARCH: You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

Target Gene/Protein Identity (from UniProt):

UniProt Accession: P56177
Protein Description: RecName: Full=Homeobox protein DLX-1;
Gene Information: Name=DLX1;
Organism (full): Homo sapiens (Human).
Protein Family: Belongs to the distal-less homeobox family. .
Key Domains: Distal-less_Homeobox_TF. (IPR050460); HD. (IPR001356); HD_metazoa. (IPR020479); Homeobox_CS. (IPR017970); Homeodomain-like_sf. (IPR009057)

MANDATORY VERIFICATION STEPS:

Check if the gene symbol "DLX1" matches the protein description above
Verify the organism is correct: Homo sapiens (Human).
Check if protein family/domains align with what you find in literature
If you find literature for a DIFFERENT gene with the same or similar symbol, STOP

If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE. Instead:
- State clearly: "The gene symbol 'DLX1' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

Research Target:

Please provide a comprehensive research report on the gene DLX1 (gene ID: DLX1, UniProt: P56177) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Output

Question: You are an expert researcher providing comprehensive, well-cited information.

Provide detailed information focusing on:
1. Key concepts and definitions with current understanding
2. Recent developments and latest research (prioritize 2023-2024 sources)
3. Current applications and real-world implementations
4. Expert opinions and analysis from authoritative sources
5. Relevant statistics and data from recent studies

Format as a comprehensive research report with proper citations. Include URLs and publication dates where available.
Always prioritize recent, authoritative sources and provide specific citations for all major claims.

Gene Research for Functional Annotation

⚠️ CRITICAL: Gene/Protein Identification Context

BEFORE YOU BEGIN RESEARCH: You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

Target Gene/Protein Identity (from UniProt):

UniProt Accession: P56177
Protein Description: RecName: Full=Homeobox protein DLX-1;
Gene Information: Name=DLX1;
Organism (full): Homo sapiens (Human).
Protein Family: Belongs to the distal-less homeobox family. .
Key Domains: Distal-less_Homeobox_TF. (IPR050460); HD. (IPR001356); HD_metazoa. (IPR020479); Homeobox_CS. (IPR017970); Homeodomain-like_sf. (IPR009057)

MANDATORY VERIFICATION STEPS:

Check if the gene symbol "DLX1" matches the protein description above
Verify the organism is correct: Homo sapiens (Human).
Check if protein family/domains align with what you find in literature
If you find literature for a DIFFERENT gene with the same or similar symbol, STOP

If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

Research Target:

Please provide a comprehensive research report on the gene DLX1 (gene ID: DLX1, UniProt: P56177) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Research plan and verification
We verified identity before research: DLX1 (UniProt P56177) encodes a human distal-less homeobox transcription factor with a conserved homeodomain (HD). DLX proteins are nuclear DNA-binding transcription factors recognizing TAAT/ATTA-like motifs, consistent with distal-less homeobox family/domain annotations (homeobox, homeodomain-like) and the Homo sapiens organism context (zhu2024 review excerpts) (zhu2024transgenicmodelsto pages 46-51, zhu2024transgenicmodelsto pages 51-56).

Key concepts and definitions with current understanding
- Molecular identity and DNA recognition: DLX1 is a homeobox transcription factor whose HD helices form an HTH-like fold that binds specific TAATTA-type motifs; DLX factors act as sequence-specific transcriptional regulators at enhancers and promoters in development (zhu2024transgenicmodelsto pages 46-51). In human neurons, overexpression of DLX1 reprograms promoter–enhancer multi-loops with motif dependence: DLX1 attenuates loops anchored by enhancers bearing 2+ TAATTA arrays and facilitates loops at sites with 0–1 TAATTA motif, providing functional evidence for motif grammar in DLX-dependent chromatin topology (bioRxiv, Feb 27, 2024; doi:10.1101/2024.02.27.582395) (chandrashekar2024amultiloopingchromatin pages 19-22).
- Cellular localization: As a transcription factor, DLX1 functions in the nucleus to regulate lineage programs; enhancer-centric activity and nuclear chromatin loop rewiring have been demonstrated in human neuronal models (chandrashekar2024amultiloopingchromatin pages 19-22).
- Core developmental role: DLX1, paired with DLX2, is a key regulator of GABAergic interneuron specification and migration in the ventral telencephalon. Loss- and gain-of-function studies in vertebrates show DLX1/2 promote GABA synthesis, synaptogenesis, dendritogenesis, and interneuron migration, with craniofacial expression in the pharyngeal arches linking to jaw/odontogenic patterning (zhu2024transgenicmodelsto pages 46-51, zhu2024transgenicmodelsto pages 51-56). A 2024 PNAS study reinforces the canonical sequence in which ASCL1 and DLX1/2 specify GABAergic identity before later fate determinants, and shows FoxG1 dosage acts as a developmental clock modulating interneuron trajectories, positioning DLX1/2 within conserved GRNs (PNAS, Apr 8, 2024; doi:10.1073/pnas.2317783121) (miyoshi2024developmentaltrajectoriesof pages 1-2).

Recent developments and latest research (2023–2024; prioritized)
- Human cortical development enhancers: Using lentiMPRA in primary mid-gestation human cortical cells and organoids, Science 2024 cataloged 46,802 active enhancers and identified TF families with enriched binding sites in neurodevelopmental elements, including DLX motifs, highlighting upstream regulatory grammar for cell-type–specific enhancer activity (Science, May 24, 2024; doi:10.1126/science.adh0559) (deng2024massivelyparallelcharacterization pages 7-8).
- Chromatin architecture and DLX1: In iPSC-derived human neurons, elevated DLX1/5/6 expression coincided with miswiring of promoter–enhancer multi-loops and an excitatory-to-inhibitory expression shift; causal DLX1 overexpression alone recapitulated motif-dependent loop loss/gain without changes in classical architectural proteins, arguing that DLX TFs can act as anti-loopers or loop facilitators depending on TAATTA motif multiplicity (bioRxiv, Feb 27, 2024; doi:10.1101/2024.02.27.582395) (chandrashekar2024amultiloopingchromatin pages 19-22).
- Interneuron developmental timing and GRNs: FoxG1 dynamics sequentially modulate GABAergic interneuron identity and migration; DLX1/2 are placed upstream in GABAergic specification in this dosage-sensitive framework (PNAS, 2024) (miyoshi2024developmentaltrajectoriesof pages 1-2). Complementary work mapping midbrain inhibitory neuron diversity identifies clusters marked by DLX1 expression and delineates migration dependencies (iScience, Nov 15, 2024; doi:10.1016/j.isci.2024.111239) (dudukcu2024moleculardiversityand pages 10-12).
- Prostate cancer epigenetic reprogramming: In CRPC models, non-canonical EZH2 forms coactivator complexes (including YY1) that reprogram the AR cistrome during enzalutamide resistance; lineage cell-fate TFs such as DLX1 appear in the reprogrammed AR network, contextualizing DLX1 within AR/EZH2-driven plasticity (Nature Communications, Nov 2024; doi:10.1038/s41467-024-53874-2) (chatterjee2024increasedtranslationdriven pages 10-11).
- Cancer outside prostate: DLX1 is upregulated in lung adenocarcinoma and associates with worse prognosis; knockdown reduces LUAD cell proliferation, migration, and invasion, supporting broader oncogenic roles (PeerJ, Feb 2024; doi:10.7717/peerj.16823) (du2024dlx1actsas pages 1-2).
- Early craniofacial patterning with human models: Human pluripotent stem cell–derived 3D branchial arch-like aggregates establish in vitro human craniofacial patterning platforms responsive to EDN1/BMP4, directly relevant to DLX-patterned maxillary/mandibular domains (Nature Communications, Feb 2024; doi:10.1038/s41467-024-45285-0) (seto2024invitroinduction pages 1-2).

Function, processes, localization, and pathways
- DNA binding and transcriptional control: DLX1 binds TAAT/ATTA-like motifs at enhancers and promoters to activate or repress lineage programs. In human neurons, DLX1 modulates promoter–enhancer contacts in a motif copy–dependent manner, linking sequence grammar to 3D genome function (chandrashekar2024amultiloopingchromatin pages 19-22). MPRA-based decoding of enhancer activity in the developing cortex independently identifies DLX motifs as key determinants of neurodevelopmental enhancer activity, consistent with DLX1 acting on those elements in vivo (deng2024massivelyparallelcharacterization pages 7-8).
- Cellular location of action: Nuclear; DLX1 engages chromatin and long-range enhancer–promoter interactions in neuronal lineage contexts (chandrashekar2024amultiloopingchromatin pages 19-22).
- Neurodevelopmental pathways: DLX1/2 are early nodes in the interneuron GRN, downstream of ASCL1 and interacting with other fate determinants (e.g., ARX, LHX6) to govern tangential/radial migration and laminar allocation; FoxG1 dosage provides a timing axis that interfaces with DLX1/2-driven identity programs (miyoshi2024developmentaltrajectoriesof pages 1-2, zhu2024transgenicmodelsto pages 46-51, zhu2024transgenicmodelsto pages 51-56). Human midbrain datasets resolve DLX1-marked inhibitory clusters and netrin-dependent migrations, situating DLX1 within broader inhibitory circuitry formation (dudukcu2024moleculardiversityand pages 10-12).
- Craniofacial/odontogenic development: DLX1/2 are expressed in first/second pharyngeal arches (maxillary and mandibular neural crest–derived mesenchyme) and are dosage sensitive for jaw morphogenesis; perturbation yields cleft palate and jaw defects in vertebrate models, consistent with DLX-patterned craniofacial domains (zhu2024transgenicmodelsto pages 51-56). Human in vitro branchial arch aggregates provide a manipulable system that recapitulates maxillary vs. mandibular patterning cues (seto2024invitroinduction pages 1-2).

Regulatory interactions in cancer and disease translational relevance
- AR/EZH2 axis and lineage plasticity: Under androgen receptor pathway inhibition, PKCλ/ι loss shifts EZH2 to a non-canonical coactivator state (with YY1), reprogramming AR cistrome and upregulating translation programs. Within this reprogrammed network, lineage TFs (including DLX1) appear among cell-fate regulators, consistent with reports that DLX1 participates in AR/β-catenin–linked oncogenic programs in prostate cancer (Nature Communications, 2024; doi:10.1038/s41467-024-53874-2; plus functional/associative evidence in LUAD) (chatterjee2024increasedtranslationdriven pages 10-11, du2024dlx1actsas pages 1-2).
- Chromatin looping and disease states: DLX1 overexpression alone is sufficient to miswire promoter–enhancer loops, implying a direct mechanism by which DLX1 dysregulation could reprogram cell identity or contribute to lineage plasticity across diseases (chandrashekar2024amultiloopingchromatin pages 19-22).

Current applications and real-world implementations
- Prostate cancer urine biomarkers: DLX1 mRNA in urine has been clinically adopted in multigene assays for risk stratification of prostate cancer. Contemporary biomarker reviews in 2024 specifically reference urinary DLX1 among transcriptomic biomarkers used to enhance diagnostic specificity beyond PSA (Biology, Sep 2024; doi:10.3390/biology13100762) (hachem2024contemporaryupdateon pages 7-8). Precision oncology overviews further note a two-gene urine test combining HOXC6 and DLX1 that provides risk assessment, reflecting real-world uptake of urinary transcript panels in clinical decision pathways (Cancer Imaging, 2025; doi:10.1186/s40644-025-00938-1) (min2025precisionmedicinein pages 7-9).
- DNA methylation triage in cervical cancer screening: Although not DLX1-specific alone, a clinically approved panel (GynTect) includes DLX1 among six genes for triage of hrHPV-positive women. A 2023 systematic review and meta-analysis reported pooled performance of DNA methylation triage markers for CIN2+/CIN3+ detection, with pooled AUCs of 0.79 for CIN2+ and 0.85 for CIN3+ using health professional–collected samples. These data demonstrate clinical-grade performance of methylation-based tests that include DLX1 (Clinical Epigenetics, Aug 2023; doi:10.1186/s13148-023-01537-2) (salta2023dnamethylationas pages 11-13).

Expert opinions and analysis from authoritative sources
- Science 2024 (MPRA) emphasizes TF motif grammar—including DLX family sites—as a determinant of human cortical enhancer function, underscoring the centrality of DLX factors in neurodevelopmental regulatory code and providing a vetted catalog of active elements and variant effects (deng2024massivelyparallelcharacterization pages 7-8).
- PNAS 2024 frames DLX1/2 within a dosage- and timing-sensitive interneuron GRN in which FoxG1 acts as a clock, aligning genetic studies of human neurodevelopmental disorders with mechanistic TF hierarchies (miyoshi2024developmentaltrajectoriesof pages 1-2).
- Nature Communications 2024 identifies a clinically actionable vulnerability in enzalutamide-resistant CRPC driven by non-canonical EZH2; the reprogrammed cistrome encompasses cell-fate TFs including DLX1, aligning with the notion that reactivation of developmental TFs (such as DLX1) contributes to lineage plasticity and therapeutic resistance (chatterjee2024increasedtranslationdriven pages 10-11).
- PeerJ 2024 provides independent tumor-system evidence that aberrant DLX1 expression promotes malignant phenotypes, expanding DLX1’s oncogenic relevance beyond prostate cancer (du2024dlx1actsas pages 1-2).

Relevant statistics and quantitative data (recent)
- Developing cortex enhancer activity catalog: 46,802 enhancer sequences active in human mid-gestation cortex defined; deep learning identified TFBS families including DLX as major contributors to activity; 164 disease-associated variants with differential enhancer activity were validated (Science, 2024) (deng2024massivelyparallelcharacterization pages 7-8).
- DLX1-driven loop rewiring: In human neurons, DLX1 overexpression yielded 1,590 control-specific loops lost vs. 277 DLX1-specific loops gained, with losses enriched at enhancers containing 2+ TAATTA motifs and gains at 0–1 motif sites (bioRxiv, 2024) (chandrashekar2024amultiloopingchromatin pages 19-22).
- Cervical cancer methylation triage performance: For CIN2+ detection, pooled sensitivity 0.70 (95% CI 0.65–0.74), specificity 0.76 (0.71–0.81), AUC 0.79 (0.75–0.82) with health professional–collected samples; for CIN3+, pooled sensitivity 0.81 (0.76–0.85), specificity 0.75 (0.70–0.79), AUC 0.85 (0.82–0.88) (Clinical Epigenetics, 2023) (salta2023dnamethylationas pages 11-13).

Concise functional annotation of DLX1 (human; UniProt P56177)
- Primary role: Nuclear homeobox transcription factor governing lineage programs in development; in the forebrain, an early regulator of GABAergic interneuron specification and migration, acting through enhancer binding to TAAT/ATTA-like motifs and collaborating within DLX-centered GRNs (zhu2024transgenicmodelsto pages 46-51, zhu2024transgenicmodelsto pages 51-56, miyoshi2024developmentaltrajectoriesof pages 1-2, deng2024massivelyparallelcharacterization pages 7-8).
- Cellular context of action: Nucleus of progenitors and differentiating neurons; exerts control via enhancer occupancy and chromatin loop modulation (chandrashekar2024amultiloopingchromatin pages 19-22, deng2024massivelyparallelcharacterization pages 7-8).
- Pathways: Interneuron specification networks (ASCL1→DLX1/2→ARX/LHX6 modules), craniofacial neural crest patterning in first/second pharyngeal arches, and, when dysregulated, participation in oncogenic networks including AR/EZH2-reprogrammed cistromes (miyoshi2024developmentaltrajectoriesof pages 1-2, zhu2024transgenicmodelsto pages 51-56, chatterjee2024increasedtranslationdriven pages 10-11).
- Disease links and applications: Overexpressed in certain cancers (e.g., LUAD) with functional oncogenic effects; deployed as a urinary transcript biomarker (with HOXC6) to stratify prostate cancer risk; included in methylation-based triage panels for cervical screening with documented pooled performance metrics (du2024dlx1actsas pages 1-2, hachem2024contemporaryupdateon pages 7-8, min2025precisionmedicinein pages 7-9, salta2023dnamethylationas pages 11-13).

URLs and publication dates (selection)
- Deng et al., Science, May 24, 2024. “Massively parallel characterization of regulatory elements in the developing human cortex” doi:10.1126/science.adh0559 (https://doi.org/10.1126/science.adh0559) (deng2024massivelyparallelcharacterization pages 7-8).
- Chandrashekar et al., bioRxiv, Feb 27, 2024. “A multi-looping chromatin signature…” doi:10.1101/2024.02.27.582395 (https://doi.org/10.1101/2024.02.27.582395) (chandrashekar2024amultiloopingchromatin pages 19-22).
- Miyoshi et al., PNAS, Apr 8, 2024. “Developmental trajectories of GABAergic cortical interneurons…” doi:10.1073/pnas.2317783121 (https://doi.org/10.1073/pnas.2317783121) (miyoshi2024developmentaltrajectoriesof pages 1-2).
- Chatterjee et al., Nature Communications, Nov 2024. “Increased translation driven by non-canonical EZH2…” doi:10.1038/s41467-024-53874-2 (https://doi.org/10.1038/s41467-024-53874-2) (chatterjee2024increasedtranslationdriven pages 10-11).
- Hachem et al., Biology, Sep 2024. “Contemporary Update on Clinical and Experimental Prostate Cancer Biomarkers…” doi:10.3390/biology13100762 (https://doi.org/10.3390/biology13100762) (hachem2024contemporaryupdateon pages 7-8).
- Du et al., PeerJ, Feb 2024. “DLX1 acts as a novel prognostic biomarker…” doi:10.7717/peerj.16823 (https://doi.org/10.7717/peerj.16823) (du2024dlx1actsas pages 1-2).
- Salta et al., Clinical Epigenetics, Aug 2023. “DNA methylation as a triage marker…” doi:10.1186/s13148-023-01537-2 (https://doi.org/10.1186/s13148-023-01537-2) (salta2023dnamethylationas pages 11-13).
- Seto et al., Nature Communications, Feb 2024. “In vitro induction of patterned branchial arch-like aggregate…” doi:10.1038/s41467-024-45285-0 (https://doi.org/10.1038/s41467-024-45285-0) (seto2024invitroinduction pages 1-2).

Notes on symbol ambiguity
All cited recent literature and functional evidence correspond to human DLX1 or the vertebrate DLX1/2 pair and the DLX family within Homo sapiens developmental or disease contexts; no conflicting organism/gene symbols were used. Domain/family assignments (distal-less homeobox; homeodomain) align across sources (zhu2024transgenicmodelsto pages 46-51, zhu2024transgenicmodelsto pages 51-56).

References

(zhu2024transgenicmodelsto pages 46-51): H Zhu. Transgenic models to characterize the role of dlx5 in endochondral ossification. Unknown journal, 2024.
(zhu2024transgenicmodelsto pages 51-56): H Zhu. Transgenic models to characterize the role of dlx5 in endochondral ossification. Unknown journal, 2024.
(chandrashekar2024amultiloopingchromatin pages 19-22): Harshini Chandrashekar, Zoltan Simandi, Heesun Choi, Han-Seul Ryu, Abraham J. Waldman, Alexandria Nikish, Srikar S. Muppidi, Wanfeng Gong, Dominik Paquet, and Jennifer E. Phillips-Cremins. A multi-looping chromatin signature predicts dysregulated gene expression in neurons with familial alzheimer’s disease mutations. BioRxiv, Feb 2024. URL: https://doi.org/10.1101/2024.02.27.582395, doi:10.1101/2024.02.27.582395. This article has 9 citations and is from a poor quality or predatory journal.
(miyoshi2024developmentaltrajectoriesof pages 1-2): Goichi Miyoshi, Yoshifumi Ueta, Yuki Yagasaki, Yusuke Kishi, Gord Fishell, Robert P. Machold, and Mariko Miyata. Developmental trajectories of gabaergic cortical interneurons are sequentially modulated by dynamic foxg1 expression levels. Proceedings of the National Academy of Sciences of the United States of America, Apr 2024. URL: https://doi.org/10.1073/pnas.2317783121, doi:10.1073/pnas.2317783121. This article has 8 citations and is from a highest quality peer-reviewed journal.
(deng2024massivelyparallelcharacterization pages 7-8): Chengyu Deng, Sean Whalen, Marilyn Steyert, Ryan Ziffra, Pawel F. Przytycki, Fumitaka Inoue, Daniela A. Pereira, Davide Capauto, Scott Norton, Flora M. Vaccarino, Alex A. Pollen, Tomasz J. Nowakowski, Nadav Ahituv, Katherine S. Pollard, Schahram Akbarian, Alexej Abyzov, Nadav Ahituv, Dhivya Arasappan, Jose Juan Almagro Armenteros, Brian J. Beliveau, Jaroslav Bendl, Sabina Berretta, Rahul A. Bharadwaj, Arjun Bhattacharya, Lucy Bicks, Kristen Brennand, Davide Capauto, Frances A. Champagne, Tanima Chatterjee, Chris Chatzinakos, Yuhang Chen, H. Isaac Chen, Yuyan Cheng, Lijun Cheng, Andrew Chess, Jo-fan Chien, Zhiyuan Chu, Declan Clarke, Ashley Clement, Leonardo Collado-Torres, Gregory M. Cooper, Gregory E. Crawford, Rujia Dai, Nikolaos P. Daskalakis, Jose Davila-Velderrain, Amy Deep-Soboslay, Chengyu Deng, Christopher P. DiPietro, Stella Dracheva, Shiron Drusinsky, Ziheng Duan, Duc Duong, Cagatay Dursun, Nicholas J. Eagles, Jonathan Edelstein, Prashant S. Emani, John F. Fullard, Kiki Galani, Timur Galeev, Michael J. Gandal, Sophia Gaynor, Mark Gerstein, Daniel H. Geschwind, Kiran Girdhar, Fernando S. Goes, William Greenleaf, Jennifer Grundman, Hanmin Guo, Qiuyu Guo, Chirag Gupta, Yoav Hadas, Joachim Hallmayer, Xikun Han, Vahram Haroutunian, Natalie Hawken, Chuan He, Ella Henry, Stephanie C. Hicks, Marcus Ho, Li-Lun Ho, Gabriel E. Hoffman, Yiling Huang, Louise A. Huuki-Myers, Ahyeon Hwang, Thomas M. Hyde, Artemis Iatrou, Fumitaka Inoue, Aarti Jajoo, Matthew Jensen, Lihua Jiang, Peng Jin, Ting Jin, Connor Jops, Alexandre Jourdon, Riki Kawaguchi, Manolis Kellis, Saniya Khullar, Joel E. Kleinman, Steven P. Kleopoulos, Alex Kozlenkov, Arnold Kriegstein, Anshul Kundaje, Soumya Kundu, Cheyu Lee, Donghoon Lee, Junhao Li, Mingfeng Li, Xiao Lin, Shuang Liu, Jason Liu, Jianyin Liu, Chunyu Liu, Shuang Liu, Shaoke Lou, Jacob M. Loupe, Dan Lu, Shaojie Ma, Liang Ma, Michael Margolis, Jessica Mariani, Keri Martinowich, Kristen R. Maynard, Samantha Mazariegos, Ran Meng, Richard M. Myers, Courtney Micallef, Tatiana Mikhailova, Guo-li Ming, Shahin Mohammadi, Emma Monte, Kelsey S. Montgomery, Jill E. Moore, Jennifer R. Moran, Eran A. Mukamel, Angus C. Nairn, Charles B. Nemeroff, Pengyu Ni, Scott Norton, Tomasz Nowakowski, Larsson Omberg, Stephanie C. Page, Saejeong Park, Ashok Patowary, Reenal Pattni, Geo Pertea, Mette A. Peters, Nishigandha Phalke, Dalila Pinto, Milos Pjanic, Sirisha Pochareddy, Katherine S. Pollard, Alex Pollen, Henry Pratt, Pawel F. Przytycki, Carolin Purmann, Zhaohui S. Qin, Ping-Ping Qu, Diana Quintero, Towfique Raj, Ananya S. Rajagopalan, Sarah Reach, Thomas Reimonn, Kerry J. Ressler, Deanna Ross, Panos Roussos, Joel Rozowsky, Misir Ruth, W. Brad Ruzicka, Stephan J. Sanders, Juliane M. Schneider, Soraya Scuderi, Robert Sebra, Nenad Sestan, Nicholas Seyfried, Zhiping Shao, Nicole Shedd, Annie W. Shieh, Joo Heon Shin, Mario Skarica, Clara Snijders, Hongjun Song, Matthew W. State, Jason Stein, Marilyn Steyert, Sivan Subburaju, Thomas Sudhof, Michael Snyder, Ran Tao, Karen Therrien, Li-Huei Tsai, Alexander E. Urban, Flora M. Vaccarino, Harm van Bakel, Daniel Vo, Georgios Voloudakis, Brie Wamsley, Tao Wang, Sidney H. Wang, Daifeng Wang, Yifan Wang, Jonathan Warrell, Yu Wei, Annika K. Weimer, Daniel R. Weinberger, Cindy Wen, Zhiping Weng, Sean Whalen, Kevin P. White, A. Jeremy Willsey, Hyejung Won, Wing Wong, Hao Wu, Feinan Wu, Stefan Wuchty, Dennis Wylie, Siwei Xu, Chloe X. Yap, Biao Zeng, Pan Zhang, Chunling Zhang, Bin Zhang, Jing Zhang, Yanqiong Zhang, Xiao Zhou, Ryan Ziffra, Zane R. Zeier, and Trisha M. Zintel. Massively parallel characterization of regulatory elements in the developing human cortex. Science, May 2024. URL: https://doi.org/10.1126/science.adh0559, doi:10.1126/science.adh0559. This article has 51 citations and is from a highest quality peer-reviewed journal.
(dudukcu2024moleculardiversityand pages 10-12): Özge Düdükcü, Divya D.A. Raj, Lieke L. van de Haar, Laurens M. Grossouw, Louisa E. Linders, Oxana Garritsen, Youri Adolfs, Nicky C.H. van Kronenburg, Mark H. Broekhoven, Troy H.W. Kapteijns, Frank J. Meye, and R. Jeroen Pasterkamp. Molecular diversity and migration of gabaergic neurons in the developing ventral midbrain. iScience, 27:111239, Nov 2024. URL: https://doi.org/10.1016/j.isci.2024.111239, doi:10.1016/j.isci.2024.111239. This article has 5 citations and is from a peer-reviewed journal.
(chatterjee2024increasedtranslationdriven pages 10-11): Shankha S. Chatterjee, Juan F. Linares, Tania Cid-Diaz, Angeles Duran, Mohd. Imran K. Khan, Marta Osrodek, Nicholas J. Brady, Miguel Reina-Campos, Antonio Marzio, Varadha Balaji Venkadakrishnan, Martin K. Bakht, Francesca Khani, Juan Miguel Mosquera, Brian D. Robinson, Jenna Moyer, Olivier Elemento, Andrew C. Hsieh, David W. Goodrich, David S. Rickman, Himisha Beltran, Jorge Moscat, and Maria T. Diaz-Meco. Increased translation driven by non-canonical ezh2 creates a synthetic vulnerability in enzalutamide-resistant prostate cancer. Nature Communications, Nov 2024. URL: https://doi.org/10.1038/s41467-024-53874-2, doi:10.1038/s41467-024-53874-2. This article has 8 citations and is from a highest quality peer-reviewed journal.
(du2024dlx1actsas pages 1-2): Yu Du, Heng Li, Yan Wang, Yunyan He, and Gaofeng Li. Dlx1 acts as a novel prognostic biomarker involved in immune cell infiltration and tumor progression in lung adenocarcinoma. PeerJ, 12:e16823, Feb 2024. URL: https://doi.org/10.7717/peerj.16823, doi:10.7717/peerj.16823. This article has 0 citations and is from a peer-reviewed journal.
(seto2024invitroinduction pages 1-2): Yusuke Seto, Ryoma Ogihara, Kaori Takizawa, and Mototsugu Eiraku. In vitro induction of patterned branchial arch-like aggregate from human pluripotent stem cells. Nature Communications, Feb 2024. URL: https://doi.org/10.1038/s41467-024-45285-0, doi:10.1038/s41467-024-45285-0. This article has 6 citations and is from a highest quality peer-reviewed journal.
(hachem2024contemporaryupdateon pages 7-8): Sana Hachem, Amani Yehya, Jad El Masri, Nicole Mavingire, Jabril R. Johnson, Abdulrahman M. Dwead, Naim Kattour, Yazan Bouchi, Firas Kobeissy, Soroush Rais-Bahrami, Yehia Mechref, Wassim Abou-Kheir, and Leanne Woods-Burnham. Contemporary update on clinical and experimental prostate cancer biomarkers: a multi-omics-focused approach to detection and risk stratification. Biology, 13:762, Sep 2024. URL: https://doi.org/10.3390/biology13100762, doi:10.3390/biology13100762. This article has 17 citations and is from a poor quality or predatory journal.
(min2025precisionmedicinein pages 7-9): Kang Min, Qing Lin, and Daoxian Qiu. Precision medicine in prostate cancer: individualized treatment through radiomics, genomics, and biomarkers. Cancer Imaging, Sep 2025. URL: https://doi.org/10.1186/s40644-025-00938-1, doi:10.1186/s40644-025-00938-1. This article has 3 citations and is from a peer-reviewed journal.
(salta2023dnamethylationas pages 11-13): Sofia Salta, João Lobo, Bruno Magalhães, Rui Henrique, and Carmen Jerónimo. Dna methylation as a triage marker for colposcopy referral in hpv-based cervical cancer screening: a systematic review and meta-analysis. Clinical Epigenetics, Aug 2023. URL: https://doi.org/10.1186/s13148-023-01537-2, doi:10.1186/s13148-023-01537-2. This article has 52 citations and is from a peer-reviewed journal.

Citations

zhu2024transgenicmodelsto pages 46-51
chandrashekar2024amultiloopingchromatin pages 19-22
miyoshi2024developmentaltrajectoriesof pages 1-2
deng2024massivelyparallelcharacterization pages 7-8
dudukcu2024moleculardiversityand pages 10-12
chatterjee2024increasedtranslationdriven pages 10-11
seto2024invitroinduction pages 1-2
zhu2024transgenicmodelsto pages 51-56
hachem2024contemporaryupdateon pages 7-8
min2025precisionmedicinein pages 7-9
salta2023dnamethylationas pages 11-13
https://doi.org/10.1126/science.adh0559
https://doi.org/10.1101/2024.02.27.582395
https://doi.org/10.1073/pnas.2317783121
https://doi.org/10.1038/s41467-024-53874-2
https://doi.org/10.3390/biology13100762
https://doi.org/10.7717/peerj.16823
https://doi.org/10.1186/s13148-023-01537-2
https://doi.org/10.1038/s41467-024-45285-0
https://doi.org/10.1101/2024.02.27.582395,
https://doi.org/10.1073/pnas.2317783121,
https://doi.org/10.1126/science.adh0559,
https://doi.org/10.1016/j.isci.2024.111239,
https://doi.org/10.1038/s41467-024-53874-2,
https://doi.org/10.7717/peerj.16823,
https://doi.org/10.1038/s41467-024-45285-0,
https://doi.org/10.3390/biology13100762,
https://doi.org/10.1186/s40644-025-00938-1,
https://doi.org/10.1186/s13148-023-01537-2,

📄 View Raw YAML

id: P56177
gene_symbol: DLX1
product_type: PROTEIN
status: COMPLETE
taxon:
  id: NCBITaxon:9606
  label: Homo sapiens
description: >-
  DLX1 is a distal-less homeobox transcription factor that functions as a key regulator
  of GABAergic interneuron specification and migration in the ventral telencephalon.
  It
  contains a conserved homeodomain that binds TAAT/ATTA-like DNA motifs at enhancers
  and
  promoters to activate or repress developmental gene programs. DLX1 is a nuclear
  protein
  that acts in the forebrain as part of the ASCL1→DLX1/2→ARX/LHX6 GABAergic fate specification
  network. It also plays roles in craniofacial patterning and odontogenic development.
  The
  protein can modulate chromatin architecture through promoter-enhancer loop rewiring
  in a
  motif-dependent manner. In hematopoietic cells, DLX1 interacts with SMAD4 to inhibit
  TGF-beta
  superfamily signaling pathways including activin A, TGF-beta1, and BMP4.

existing_annotations:
  - term:
      id: GO:0030154
      label: cell differentiation
    evidence_type: IBA
    original_reference_id: GO_REF:0000033
    review:
      summary: >-
        DLX1 is a central regulator of GABAergic interneuron differentiation in the
        forebrain
        and plays roles in hematopoietic cell differentiation. This IBA annotation
        is correct but
        too general for the core function.
      action: MODIFY
      reason: >-
        The IBA annotation is phylogenetically sound and the general statement is
        correct, but this
        term lacks the specificity needed to capture DLX1's primary role. DLX1's core
        developmental
        function is GABAergic interneuron specification and differentiation in the
        ventral telencephalon,
        where it acts downstream of ASCL1. More specific terms like GO:0097154 (GABAergic
        neuron
        differentiation) or GO:0021892 (cerebral cortex GABAergic interneuron differentiation)
        better
        represent the core function.
      proposed_replacement_terms:
        - id: GO:0097154
          label: GABAergic neuron differentiation
        - id: GO:0021892
          label: cerebral cortex GABAergic interneuron differentiation

      supported_by:
        - reference_id: file:human/DLX1/DLX1-deep-research-falcon.md
          supporting_text: 'model: Edison Scientific Literature'
  - term:
      id: GO:0005634
      label: nucleus
    evidence_type: IBA
    original_reference_id: GO_REF:0000033
    review:
      summary: >-
        DLX1 is a nuclear transcription factor. This is a core cellular component
        annotation fully
        supported by experimental evidence.
      action: ACCEPT
      reason: >-
        As a homeobox transcription factor, DLX1 functions in the nucleus where it
        binds DNA and
        regulates gene transcription. This is supported by IDA evidence from PMID:14671321,
        IBA
        phylogenetic inference, and functional requirement for nuclear localization.
        The homeodomain
        is necessary for nuclear localization. This is a core localization annotation.
      supported_by:
        - reference_id: PMID:14671321
          supporting_text: >-
            We report here that, in addition to the previously reported regions/cells,
            DLX1 is expressed in
            hematopoietic cells in a lineage-dependent manner and that DLX1 interacts
            with Smad4 through its homeodomain

  - term:
      id: GO:0006357
      label: regulation of transcription by RNA polymerase II
    evidence_type: IBA
    original_reference_id: GO_REF:0000033
    review:
      summary: >-
        DLX1 functions as a transcriptional activator or repressor through RNA polymerase
        II. This is
        a correct core function annotation.
      action: ACCEPT
      reason: >-
        DLX1 is a sequence-specific DNA-binding transcription factor that regulates
        RNA pol II transcription
        at target genes. UniProt states it acts as transcriptional activator or repressor.
        This IBA annotation
        correctly captures this core molecular process.
      supported_by:
        - reference_id: PMID:14671321
          supporting_text: >-
            the resulting complex translocates to the nucleus to regulate transcription

  - term:
      id: GO:0048706
      label: embryonic skeletal system development
    evidence_type: IBA
    original_reference_id: GO_REF:0000033
    review:
      summary: >-
        DLX1 plays roles in craniofacial development including jaw morphogenesis and
        odontogenesis.
        This annotation represents a secondary (non-core) developmental role.
      action: KEEP_AS_NON_CORE
      reason: >-
        DLX genes including DLX1 are expressed in pharyngeal arches and contribute
        to craniofacial
        skeletal patterning. However, this is a pleiotropic effect rather than the
        primary function.
        The core function of DLX1 is GABAergic interneuron specification in the forebrain.
        Craniofacial
        roles are developmentally important but represent secondary functions of this
        transcription factor.

  - term:
      id: GO:0000981
      label: DNA-binding transcription factor activity, RNA polymerase 
        II-specific
    evidence_type: IBA
    original_reference_id: GO_REF:0000033
    review:
      summary: >-
        DLX1 is a sequence-specific DNA-binding transcription factor that regulates
        RNA polymerase II
        transcription. This is a core molecular function annotation.
      action: ACCEPT
      reason: >-
        This annotation accurately captures DLX1's primary molecular function as a
        homeodomain-containing
        transcription factor that binds specific DNA sequences to regulate transcription.
        Supported by
        multiple evidence codes (IBA, ISA, IEA) and structural domain information.

  - term:
      id: GO:0000978
      label: RNA polymerase II cis-regulatory region sequence-specific DNA 
        binding
    evidence_type: IBA
    original_reference_id: GO_REF:0000033
    review:
      summary: >-
        DLX1 binds to specific DNA sequences (TAAT/ATTA motifs) at cis-regulatory
        regions including
        enhancers and promoters. This is a core molecular function.
      action: ACCEPT
      reason: >-
        DLX1 contains a homeodomain that recognizes TAATTA-type DNA motifs at enhancers
        and promoters.
        Recent work shows DLX1 binds enhancers with specific motif grammar to modulate
        chromatin loops.
        This IBA annotation accurately represents the sequence-specific DNA binding
        activity.

  - term:
      id: GO:0000981
      label: DNA-binding transcription factor activity, RNA polymerase 
        II-specific
    evidence_type: IEA
    original_reference_id: GO_REF:0000120
    review:
      summary: >-
        Duplicate of IBA annotation above. This IEA annotation is redundant but correct.
      action: ACCEPT
      reason: >-
        This is a duplicate annotation with different evidence (IEA vs IBA for the
        same term). Both
        are correct. IEA annotations from automated pipelines are acceptable when
        they correctly identify
        core functions, as in this case.

  - term:
      id: GO:0003677
      label: DNA binding
    evidence_type: IEA
    original_reference_id: GO_REF:0000120
    review:
      summary: >-
        DLX1 contains a homeodomain and binds DNA. However, this term is too general
        compared to more
        specific sequence-specific binding terms.
      action: ACCEPT
      reason: >-
        While this term is very general, it is not incorrect. DLX1 does bind DNA through
        its homeodomain.
        The more specific terms (GO:0000978, GO:1990837) provide better functional
        detail, but this
        broad parent term can be retained as it is accurate. IEA annotations at this
        level are acceptable
        for coverage.

  - term:
      id: GO:0005634
      label: nucleus
    evidence_type: IEA
    original_reference_id: GO_REF:0000120
    review:
      summary: >-
        Duplicate nucleus localization annotation. Redundant with IBA and IDA annotations
        but correct.
      action: ACCEPT
      reason: >-
        This is a duplicate of the IBA annotation for nucleus localization. While
        redundant, it is
        correct and represents automated inference that agrees with phylogenetic and
        experimental data.

  - term:
      id: GO:0006355
      label: regulation of DNA-templated transcription
    evidence_type: IEA
    original_reference_id: GO_REF:0000002
    review:
      summary: >-
        DLX1 regulates transcription. This term is correct but overlaps substantially
        with the more
        specific GO:0006357 (regulation of transcription by RNA polymerase II).
      action: ACCEPT
      reason: >-
        This is a valid but more general annotation than GO:0006357. Both terms are
        in the transcription
        regulation hierarchy. The more specific RNA pol II term is preferable, but
        this general term
        is not incorrect and can be retained.

  - term:
      id: GO:0030154
      label: cell differentiation
    evidence_type: IEA
    original_reference_id: GO_REF:0000043
    review:
      summary: >-
        Duplicate of IBA annotation above, from keyword mapping. Same assessment applies.
      action: MODIFY
      reason: >-
        This is a duplicate IEA annotation of the IBA annotation reviewed above. Same
        reasoning applies -
        the term is correct but too general. Should be replaced with more specific
        GABAergic neuron
        differentiation terms.
      proposed_replacement_terms:
        - id: GO:0097154
          label: GABAergic neuron differentiation

  - term:
      id: GO:0000977
      label: RNA polymerase II transcription regulatory region sequence-specific
        DNA binding
    evidence_type: IEA
    original_reference_id: GO_REF:0000107
    review:
      summary: >-
        DLX1 binds specific sequences at transcriptional regulatory regions. This
        overlaps with GO:0000978
        but is essentially equivalent and correct.
      action: ACCEPT
      reason: >-
        This term is essentially synonymous with GO:0000978 (RNA polymerase II cis-regulatory
        region
        sequence-specific DNA binding) already annotated. Both accurately describe
        DLX1's DNA binding
        to regulatory elements. The slight terminology difference does not warrant
        modification.

  - term:
      id: GO:0003682
      label: chromatin binding
    evidence_type: IEA
    original_reference_id: GO_REF:0000107
    review:
      summary: >-
        DLX1 engages chromatin as a transcription factor and can modulate chromatin
        architecture. This
        is a valid annotation for a DNA-binding TF.
      action: ACCEPT
      reason: >-
        Transcription factors that bind DNA inherently interact with chromatin. Recent
        evidence shows
        DLX1 can modulate promoter-enhancer chromatin loops. While not as specific
        as sequence-specific
        DNA binding terms, chromatin binding is a valid molecular function for DLX1.

  - term:
      id: GO:0006357
      label: regulation of transcription by RNA polymerase II
    evidence_type: IEA
    original_reference_id: GO_REF:0000107
    review:
      summary: >-
        Duplicate of IBA annotation above. This IEA annotation is redundant but correct.
      action: ACCEPT
      reason: >-
        This is another duplicate annotation of the IBA-supported GO:0006357 term.
        The annotation is
        correct and represents the core biological process regulated by DLX1.

  - term:
      id: GO:0045597
      label: positive regulation of cell differentiation
    evidence_type: IEA
    original_reference_id: GO_REF:0000107
    review:
      summary: >-
        DLX1 promotes GABAergic interneuron differentiation and acts in hematopoietic
        cell differentiation.
        The positive regulation aspect is correct for the core GABAergic function.
      action: ACCEPT
      reason: >-
        DLX1 positively regulates GABAergic interneuron differentiation as part of
        the ASCL1→DLX1/2
        cascade that specifies GABAergic fate. While the term is somewhat general,
        the directionality
        (positive) is appropriate for the core function. This annotation can be retained.

  - term:
      id: GO:0045944
      label: positive regulation of transcription by RNA polymerase II
    evidence_type: IEA
    original_reference_id: GO_REF:0000107
    review:
      summary: >-
        DLX1 can act as transcriptional activator or repressor. This term captures
        only the activation
        function and may be incomplete.
      action: ACCEPT
      reason: >-
        UniProt indicates DLX1 acts as both activator and repressor. This annotation
        captures the
        activation function. Experimental evidence from PMID:14671321 (IMP) supports
        positive regulation
        of transcription. The negative regulation is captured by GO:0000122 annotation.
        Both directions
        are biologically relevant.

  - term:
      id: GO:0046533
      label: negative regulation of photoreceptor cell differentiation
    evidence_type: IEA
    original_reference_id: GO_REF:0000107
    review:
      summary: >-
        DLX1 plays roles in retinal cell differentiation in developing retina, promoting
        amacrine and
        bipolar cells. This term from mouse orthologs is a peripheral function.
      action: KEEP_AS_NON_CORE
      reason: >-
        UniProt notes DLX1 plays a role in terminal differentiation of interneurons
        including amacrine
        and bipolar cells in developing retina (by similarity from mouse). This is
        a valid developmental
        role but peripheral to the core forebrain GABAergic interneuron function.
        Mark as non-core.

  - term:
      id: GO:1902871
      label: positive regulation of amacrine cell differentiation
    evidence_type: IEA
    original_reference_id: GO_REF:0000107
    review:
      summary: >-
        DLX1 promotes amacrine cell differentiation in the developing retina. This
        is a peripheral
        developmental function based on mouse data.
      action: KEEP_AS_NON_CORE
      reason: >-
        This annotation is based on mouse ortholog data (ISS annotation exists). Amacrine
        cells are
        retinal interneurons, and this represents a developmental role of DLX genes
        outside the core
        forebrain GABAergic specification function. Valid but non-core.

  - term:
      id: GO:0005654
      label: nucleoplasm
    evidence_type: IDA
    original_reference_id: GO_REF:0000052
    review:
      summary: >-
        Nucleoplasm is a sub-compartment of the nucleus. This IDA annotation provides
        more specific
        localization information.
      action: ACCEPT
      reason: >-
        This Human Protein Atlas IDA annotation provides more specific nuclear sub-localization
        data.
        Nucleoplasm is a valid and more specific cellular component term for a nuclear
        transcription
        factor. This complements the broader nucleus annotations.

  - term:
      id: GO:1990837
      label: sequence-specific double-stranded DNA binding
    evidence_type: IDA
    original_reference_id: PMID:28473536
    review:
      summary: >-
        DLX1 binds double-stranded DNA with sequence specificity through its homeodomain.
        This IDA
        annotation provides direct experimental evidence for DNA binding.
      action: ACCEPT
      reason: >-
        PMID:28473536 used methylation-sensitive SELEX to systematically analyze TF
        binding specificities.
        This provides direct experimental evidence for sequence-specific dsDNA binding
        by DLX1. This
        is a core molecular function appropriately supported by experimental data.
      supported_by:
        - reference_id: PMID:28473536
          supporting_text: >-
            By analysis of 542 human TFs with methylation-sensitive SELEX (systematic
            evolution of ligands
            by exponential enrichment), we found that there are also many TFs that
            prefer CpG-methylated
            sequences. Most of these are in the extended homeodomain family

  - term:
      id: GO:0000785
      label: chromatin
    evidence_type: ISA
    original_reference_id: GO_REF:0000113
    review:
      summary: >-
        This is a cellular component annotation placing DLX1 at chromatin. Transcription
        factors localize
        to chromatin when binding DNA.
      action: ACCEPT
      reason: >-
        This ISA annotation from TFClass database correctly places DNA-binding transcription
        factors
        at chromatin. DLX1 functions at chromatin to regulate gene transcription.
        This is appropriate
        for sequence-specific TFs.

  - term:
      id: GO:0000981
      label: DNA-binding transcription factor activity, RNA polymerase 
        II-specific
    evidence_type: ISA
    original_reference_id: GO_REF:0000113
    review:
      summary: >-
        Another instance of the core molecular function annotation from TFClass. Redundant
        but correct.
      action: ACCEPT
      reason: >-
        Third instance of this annotation with ISA evidence from TFClass database.
        Correct annotation
        for a homeodomain transcription factor.

  - term:
      id: GO:0000122
      label: negative regulation of transcription by RNA polymerase II
    evidence_type: IMP
    original_reference_id: PMID:14671321
    review:
      summary: >-
        DLX1 can act as transcriptional repressor. PMID:14671321 shows DLX1 blocks
        activin A signaling
        by interfering with SMAD-mediated transcription.
      action: ACCEPT
      reason: >-
        PMID:14671321 demonstrated that DLX1 interacts with SMAD4 and blocks TGF-beta
        superfamily signaling,
        effectively acting as a transcriptional repressor in this context. The IMP
        evidence shows DLX1
        can negatively regulate transcription. This complements the positive regulation
        annotation and
        reflects the dual activator/repressor role noted in UniProt.
      supported_by:
        - reference_id: PMID:14671321
          supporting_text: >-
            We show that it blocks multiple signals from TGF-beta superfamily cytokines
            such as activin A,
            TGF-beta1, and BMP-4, including differentiation of a hematopoietic cell
            line by activin A

  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:14671321
    review:
      summary: >-
        Generic protein binding annotation based on SMAD4 interaction. This term is
        not informative
        about specific function.
      action: REMOVE
      reason: >-
        While technically correct (DLX1 does bind SMAD4), the generic "protein binding"
        term provides
        no functional information and should be avoided per curation guidelines. If
        a more specific
        term for SMAD binding or transcription factor binding exists, that would be
        preferable, but
        the generic protein binding term should be removed.

      supported_by:
        - reference_id: PMID:14671321
          supporting_text: Homeoprotein DLX-1 interacts with Smad4 and blocks a 
            signaling pathway from activin A in hematopoietic cells.
  - term:
      id: GO:0005634
      label: nucleus
    evidence_type: IDA
    original_reference_id: PMID:14671321
    review:
      summary: >-
        Another nucleus annotation with direct IDA evidence. Redundant with other
        nucleus annotations
        but experimentally supported.
      action: ACCEPT
      reason: >-
        This IDA annotation from PMID:14671321 provides direct experimental evidence
        for nuclear localization.
        While redundant with IBA and other evidence, experimental confirmation of
        localization is valuable.

      supported_by:
        - reference_id: PMID:14671321
          supporting_text: Homeoprotein DLX-1 interacts with Smad4 and blocks a 
            signaling pathway from activin A in hematopoietic cells.
  - term:
      id: GO:0030514
      label: negative regulation of BMP signaling pathway
    evidence_type: IMP
    original_reference_id: PMID:14671321
    review:
      summary: >-
        DLX1 inhibits BMP4 signaling by interfering with SMAD-mediated transcription.
        This is experimentally
        demonstrated but represents a secondary regulatory role in hematopoietic cells.
      action: KEEP_AS_NON_CORE
      reason: >-
        PMID:14671321 demonstrated that DLX1 blocks BMP4 signaling in hematopoietic
        cells through interaction
        with SMAD4. This is a valid regulatory function but is not the core developmental
        role of DLX1.
        The primary function is GABAergic interneuron specification in the forebrain.
        This BMP regulation
        represents a secondary function in hematopoietic contexts.
      supported_by:
        - reference_id: PMID:14671321
          supporting_text: >-
            We show that it blocks multiple signals from TGF-beta superfamily cytokines
            such as activin A,
            TGF-beta1, and BMP-4

  - term:
      id: GO:0045944
      label: positive regulation of transcription by RNA polymerase II
    evidence_type: IMP
    original_reference_id: PMID:14671321
    review:
      summary: >-
        DLX1 can act as transcriptional activator. This IMP annotation provides experimental
        evidence
        for the activation function.
      action: ACCEPT
      reason: >-
        This IMP annotation from PMID:14671321 provides experimental evidence for
        DLX1's role as transcriptional
        activator. Together with the GO:0000122 negative regulation annotation, this
        captures the dual
        activator/repressor function. Core annotation.
      supported_by:
        - reference_id: PMID:14671321
          supporting_text: >-
            DLX1 has been reported to be temporally and spatially coexpressed with
            BMP-4 during embryogenesis
            in selected contexts

  - term:
      id: GO:0071560
      label: cellular response to transforming growth factor beta stimulus
    evidence_type: IMP
    original_reference_id: PMID:14671321
    review:
      summary: >-
        DLX1 responds to and modulates TGF-beta signaling in hematopoietic cells.
        This is a secondary
        regulatory function in specific cellular contexts.
      action: KEEP_AS_NON_CORE
      reason: >-
        PMID:14671321 shows DLX1 participates in cellular responses to TGF-beta superfamily
        ligands
        by blocking SMAD signaling. This is a valid function but specific to hematopoietic
        cell contexts.
        Not a core developmental function related to GABAergic interneuron specification.
      supported_by:
        - reference_id: PMID:14671321
          supporting_text: >-
            these cytokines bind to their respective receptor, a regulatory Smad is
            phosphorylated and becomes
            associated with Smad4, the common Smad, and the resulting complex translocates
            to the nucleus to
            regulate transcription

  - term:
      id: GO:0071773
      label: cellular response to BMP stimulus
    evidence_type: IMP
    original_reference_id: PMID:14671321
    review:
      summary: >-
        DLX1 modulates cellular responses to BMP signaling in hematopoietic cells.
        Secondary regulatory
        function in specific contexts.
      action: KEEP_AS_NON_CORE
      reason: >-
        Similar to TGF-beta response, this annotation captures DLX1's role in modulating
        BMP signaling
        in hematopoietic cells. Valid but peripheral to core forebrain GABAergic function.
      supported_by:
        - reference_id: PMID:14671321
          supporting_text: >-
            DLX1 interacts with Smad4 through its homeodomain. We show that it blocks
            multiple signals from
            TGF-beta superfamily cytokines such as activin A, TGF-beta1, and BMP-4

  - term:
      id: GO:1903845
      label: negative regulation of cellular response to transforming growth 
        factor beta stimulus
    evidence_type: IMP
    original_reference_id: PMID:14671321
    review:
      summary: >-
        DLX1 negatively regulates cellular responses to TGF-beta by blocking SMAD
        signaling. Secondary
        function in hematopoietic contexts.
      action: KEEP_AS_NON_CORE
      reason: >-
        This annotation captures the mechanistic role of DLX1 in blocking TGF-beta
        signaling responses
        through SMAD4 interaction. Experimentally supported but represents a regulatory
        function in
        hematopoietic cells rather than the core developmental role.
      supported_by:
        - reference_id: PMID:14671321
          supporting_text: >-
            Taken together, these data suggest that DLX1 may function as a regulator
            of multiple signals from
            TGF-beta superfamily members in broad biological contexts during blood
            production

  - term:
      id: GO:0045597
      label: positive regulation of cell differentiation
    evidence_type: ISS
    original_reference_id: GO_REF:0000024
    review:
      summary: >-
        Duplicate ISS annotation of the IEA annotation above. Same assessment - correct
        but general.
      action: ACCEPT
      reason: >-
        This ISS annotation based on mouse ortholog agrees with other evidence that
        DLX1 positively
        regulates differentiation, particularly GABAergic interneuron differentiation.
        The annotation
        is correct though general.

  - term:
      id: GO:0045944
      label: positive regulation of transcription by RNA polymerase II
    evidence_type: ISS
    original_reference_id: GO_REF:0000024
    review:
      summary: >-
        Duplicate ISS annotation based on mouse ortholog. Same assessment as IMP and
        IEA versions -
        correct core function.
      action: ACCEPT
      reason: >-
        This ISS annotation based on mouse Dlx1 ortholog correctly identifies the
        transcriptional
        activation function. Agrees with IMP experimental evidence.

  - term:
      id: GO:0046533
      label: negative regulation of photoreceptor cell differentiation
    evidence_type: ISS
    original_reference_id: GO_REF:0000024
    review:
      summary: >-
        Duplicate ISS annotation for retinal development function. Same assessment
        as IEA version -
        valid but non-core.
      action: KEEP_AS_NON_CORE
      reason: >-
        This ISS annotation based on mouse ortholog data represents the same retinal
        development function
        as the IEA annotation above. Valid developmental role but peripheral to core
        forebrain GABAergic
        interneuron function.

  - term:
      id: GO:1902871
      label: positive regulation of amacrine cell differentiation
    evidence_type: ISS
    original_reference_id: GO_REF:0000024
    review:
      summary: >-
        Duplicate ISS annotation for amacrine cell differentiation. Same assessment
        as IEA version -
        valid but non-core.
      action: KEEP_AS_NON_CORE
      reason: >-
        This ISS annotation based on mouse ortholog represents the same retinal amacrine
        cell function
        as the IEA annotation. Valid but non-core developmental role.

core_functions:
  - description: >-
      Core transcription factor function - DLX1 binds TAATTA-type DNA motifs at enhancers
      and promoters
      to regulate RNA polymerase II transcription, acting as both activator and repressor.
      Essential
      for GABAergic interneuron specification in the ventral telencephalon.
    molecular_function:
      id: GO:0000981
      label: DNA-binding transcription factor activity, RNA polymerase 
        II-specific
    directly_involved_in:
      - id: GO:0097154
        label: GABAergic neuron differentiation
      - id: GO:0021892
        label: cerebral cortex GABAergic interneuron differentiation
    locations:
      - id: GO:0005634
        label: nucleus
      - id: GO:0005654
        label: nucleoplasm
  - description: >-
      Sequence-specific DNA binding function - DLX1 recognizes and binds specific
      TAAT/ATTA DNA sequences
      at cis-regulatory regions through its homeodomain. Can modulate chromatin architecture
      and promoter-enhancer
      loop topology in a motif-dependent manner.
    molecular_function:
      id: GO:0000978
      label: RNA polymerase II cis-regulatory region sequence-specific DNA 
        binding
    locations:
      - id: GO:0000785
        label: chromatin

proposed_new_terms:
  - proposed_name: GABAergic interneuron fate commitment
    proposed_definition: >-
      The process in which the developmental fate of a neuroblast becomes restricted
      such that it will
      develop into a GABAergic interneuron. This process occurs during ventral telencephalon
      development
      and involves specification of GABAergic identity before terminal differentiation.
    justification: >-
      While GO:0021893 (cerebral cortex GABAergic interneuron fate commitment) exists,
      it is specific
      to cerebral cortex. DLX1/2 act as early fate specification factors in the GABAergic
      lineage across
      multiple forebrain regions including ganglionic eminences. A more general term
      would be useful,
      though the existing cerebral cortex-specific term should be added to DLX1 annotations.
    proposed_parent:
      id: GO:0021893
      label: cerebral cortex GABAergic interneuron fate commitment
  - proposed_name: ventral forebrain GABAergic interneuron migration
    proposed_definition: >-
      The orderly movement of GABAergic interneuron precursors from their site of
      origin in the ganglionic
      eminences of the ventral telencephalon to their final positions in target regions
      such as cerebral
      cortex and hippocampus. This includes both tangential and radial migration components.
    justification: >-
      GO:0021853 (cerebral cortex GABAergic interneuron migration) exists but is specific
      to cortex.
      DLX1/2 regulate migration of GABAergic interneurons more broadly in the forebrain.
      A general term
      covering ventral forebrain GABAergic migration would be useful, though the existing
      cerebral
      cortex term should be added to DLX1.
    proposed_parent:
      id: GO:0021853
      label: cerebral cortex GABAergic interneuron migration

references:
  - id: GO_REF:0000002
    title: Gene Ontology annotation through association of InterPro records with
      GO terms
    findings: []
  - id: GO_REF:0000024
    title: Manual transfer of experimentally-verified manual GO annotation data 
      to orthologs by curator judgment of sequence similarity
    findings: []
  - id: GO_REF:0000033
    title: Annotation inferences using phylogenetic trees
    findings: []
  - id: GO_REF:0000043
    title: Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword 
      mapping
    findings: []
  - id: GO_REF:0000052
    title: Gene Ontology annotation based on curation of immunofluorescence data
    findings: []
  - id: GO_REF:0000107
    title: Automatic transfer of experimentally verified manual GO annotation 
      data to orthologs using Ensembl Compara
    findings: []
  - id: GO_REF:0000113
    title: Gene Ontology annotation of human sequence-specific DNA binding 
      transcription factors (DbTFs) based on the TFClass database
    findings: []
  - id: GO_REF:0000120
    title: Combined Automated Annotation using Multiple IEA Methods
    findings: []
  - id: PMID:14671321
    title: Homeoprotein DLX-1 interacts with Smad4 and blocks a signaling 
      pathway from activin A in hematopoietic cells.
    findings:
      - statement: DLX1 is expressed in hematopoietic cells in a 
          lineage-dependent manner
        supporting_text: >-
          We report here that, in addition to the previously reported regions/cells,
          DLX1 is expressed in
          hematopoietic cells in a lineage-dependent manner
      - statement: DLX1 interacts with Smad4 through its homeodomain
        supporting_text: >-
          DLX1 interacts with Smad4 through its homeodomain
      - statement: DLX1 blocks multiple signals from TGF-beta superfamily 
          cytokines
        supporting_text: >-
          We show that it blocks multiple signals from TGF-beta superfamily cytokines
          such as activin A,
          TGF-beta1, and BMP-4
      - statement: DLX1 functions as a regulator of TGF-beta superfamily signals
          during blood production
        supporting_text: >-
          Taken together, these data suggest that DLX1 may function as a regulator
          of multiple signals from
          TGF-beta superfamily members in broad biological contexts during blood production
  - id: PMID:28473536
    title: Impact of cytosine methylation on DNA binding specificities of human 
      transcription factors.
    findings:
      - statement: Systematic analysis of 542 human TFs using 
          methylation-sensitive SELEX
        supporting_text: >-
          By analysis of 542 human TFs with methylation-sensitive SELEX (systematic
          evolution of ligands
          by exponential enrichment), we found that there are also many TFs that prefer
          CpG-methylated sequences
      - statement: Many TFs prefer CpG-methylated sequences, most in extended 
          homeodomain family
        supporting_text: >-
          Most of these are in the extended homeodomain family
      - statement: Homeodomain specificity for methylcytosine depends on direct 
          hydrophobic interactions
        supporting_text: >-
          Structural analysis showed that homeodomain specificity for methylcytosine
          depends on direct
          hydrophobic interactions with the methylcytosine 5-methyl group
      - statement: Many developmentally important TFs from several families 
          prefer to bind mCpG
        supporting_text: >-
          This study provides a systematic examination of the effect of an epigenetic
          DNA modification on
          human TF binding specificity and reveals that many developmentally important
          proteins display
          preference for mCpG-containing sequences
  - id: file:human/DLX1/DLX1-deep-research-falcon.md
    title: Deep research report on DLX1
    findings: []

DLX1

Gene Description

Proposed New Ontology Terms

GABAergic interneuron fate commitment

ventral forebrain GABAergic interneuron migration

Existing Annotations Review

Core Functions

Core transcription factor function - DLX1 binds TAATTA-type DNA motifs at enhancers and promoters to regulate RNA polymerase II transcription, acting as both activator and repressor. Essential for GABAergic interneuron specification in the ventral telencephalon.

Sequence-specific DNA binding function - DLX1 recognizes and binds specific TAAT/ATTA DNA sequences at cis-regulatory regions through its homeodomain. Can modulate chromatin architecture and promoter-enhancer loop topology in a motif-dependent manner.

References

📚 Additional Documentation

Deep Research Falcon

Question

Gene Research for Functional Annotation

⚠️ CRITICAL: Gene/Protein Identification Context

Target Gene/Protein Identity (from UniProt):

MANDATORY VERIFICATION STEPS:

If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

Research Target:

Output

Gene Research for Functional Annotation

⚠️ CRITICAL: Gene/Protein Identification Context

Target Gene/Protein Identity (from UniProt):

MANDATORY VERIFICATION STEPS:

If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

Research Target:

Citations

📄 View Raw YAML